Skip to main content

Drug Interactions between cholera vaccine, live and tetanus immune globulin

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

tetanus immune globulin cholera vaccine, live

Applies to: tetanus immune globulin and cholera vaccine, live

Tetanus immune globulin may interfere with your body's immune response to cholera vaccine, live. If you have been treated with tetanus immune globulin or received a blood product, your doctor may suggest you wait a certain period of time before being vaccinated with cholera vaccine, live. If you were vaccinated with cholera vaccine, live shortly before or after tetanus immune globulin, revaccination and/or laboratory testing for vaccine immunity may be necessary. The immunizing doctor should be informed of recent therapy with tetanus immune globulin or any blood product so that appropriate measures and/or precautions can be taken. It is important to tell the doctor about all other medications being used, including vitamins and herbs. Do not stop using any medications without first talking to the doctor.

Drug and food interactions

Moderate

cholera vaccine, live food

Applies to: cholera vaccine, live

Administration of cholera vaccine, live with food or drink may reduce its effectiveness. Avoid eating or drinking for 60 minutes before and after taking cholera vaccine, live.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer